-1 C
London
Monday, November 29, 2021

Ikervis eye drops series withdrawn from the market. GIS Warning

Must read

- Advertisement -


The Chief Pharmaceutical Inspectorate (GIF) announced in a statement that it is withdrawing from the market a series of Ikervis eye drops throughout the country. They are used to treat severe keratitis and dry eye syndrome.

Product details

“GIF withdraws the medicinal product from the market: Ikervis (Ciclosporinum), 1 mg / ml, eye drops, emulsion; batch number: 4N78E; expiry date: 05.2023; MAH: SANTEN Oy” – announced on Monday on Twitter institution.

GIF Warning

“The Main Pharmaceutical Inspectorate in the Rapid Alert system received information from the European Medicines Agency about the detection of crystals of the active substance in certain batches of the Ikervis medicinal product, 1 mg / ml eye drops, emulsion” – explained the GIF in its decision.

- Advertisement -

FULL CONTENT OF GIF DECISIONS >>>

A series of eye drops withdrawn from the market

Ikervis contains cyclosporine, which is an immunosuppressive medicine. It has anti-inflammatory properties. It is used to treat severe keratitis and to treat dry eye syndrome in patients who do not feel better despite the use of artificial tear preparations.

Main photo source: Shutterstock



Source link

More articles

- Advertisement -

Latest article